Marcella Grillo

Ms. Marcella Grillo

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 April 2024 in Biomedicines
Verified
Journal Article
Open access
PDF file
NBNatali Barakat
Natali Barakat
HJHimanshi Jangir
Himanshi Jangir
LGLeandro Gallo
Leandro Gallo
MGMarcella Grillo
Marcella Grillo
XGXiufang (Nadine) Guo
Xiufang (Nadine) Guo
JHJames J. Hickman
James J. Hickman
In vitro culture longevity has long been a concern for disease modeling and drug testing when using contractable cells. The dynamic nature of certain cells, such as skeletal muscle, contributes to cell surface release, which limits the system’s ability to conduct long-term studies. This study hypothesized that regulating the extracellular matrix (ECM) dynamics should be able to prolong cell attachment on a culture surface. Human induced pluripotent stem cell (iPSC)-derived skeletal muscle (SKM) culture was utilized to test this hypothesis due to its forceful contractions in mature muscle culture, which can cause cell detachment. By specifically inhibiting matrix metalloproteinases (MMPs) that work to digest components of the ECM, it was shown that the SKM culture remained adhered for longer periods of time, up to 80 days. Functional testing of myofibers indicated that cells treated with the MMP inhibitors, tempol, and doxycycline, displayed a significantly reduced fatigue index, although the fidelity was not affected, while those treated with the MMP inducer, PMA, indicated a premature detachment and increased fatigue index. The MMP-modulating activity by the inhibitors and inducer was further validated by gel zymography analysis, where the MMP inhibitor showed minimally active MMPs, while the inducer-treated cells indicated high MMP activity. These data support the hypotheses that regulating the ECM dynamics can help maximize in vitro myotube longevity. This proof-of-principle strategy would benefit the modeling of diseases that require a long time to develop and the evaluation of chronic effects of potential therapeutics.

27 September 2025 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
KAKaveena Autar
Kaveena Autar
XGXiufang Guo
Xiufang Guo
HPHaley Powell
Haley Powell
APAakash Patel
Aakash Patel
MMMridu Malik
Mridu Malik
JHJames J. Hickman
James J. Hickman
Cortisol, the main stress hormone of the hypothalamic-pituitary-adrenal (HPA) axis, has been hypothesized to cause considerable detriment to cognitive function in both a time and concentration-dependent manner. However, there is a current lack of functional in vitro models available to evaluate the stress condition. Long-term potentiation (LTP) has served as a quantitative correlate for memory and learning through in vitro neuronal network responses to electrical stimuli, where a high-frequency stimulation (HFS) protocol on microelectrode arrays (MEAs) evaluates synaptic integrity related to higher-order cognition. As a novel alternative to animal studies, this study has employed a human iPSC-cortical neuron organ-on-a-chip (HoaC) system to establish a stress phenotype for synaptic dysfunction and evaluate the effects of therapeutic compounds to ameliorate stress-induced cognitive dysfunction. In our HoaC system, cortisol exposure was found to alter cortical neuron LTP, synaptic integrity, cellular morphology, and electrophysiology, confirming a cortisol-induced stress phenotype consistent with previous findings. Using this novel system, we investigated the ability of Echinacea purpurea and its active ingredient, dodeca-2E,4E,8Z,10Z-tetraenoic acid N-isobutyl amide (dodeca), to mitigate stress-induced functional decline. Following exposure to chronic stress (1 µM cortisol dosing for 7 days), both Echinacea purpurea and dodeca were found to significantly alleviate cortisol-induced cortical neuron stress in a time-dependent rescue of LTP. Together, these results characterize a novel, biologically-relevant model of neurological stress, and highlight its utility in identifying new therapeutic compounds capable of restoring stress-induced cortical neuron network deficits.

20 May 2024 in Research Square
Verified
Preprint
Open access
PDF file
JCJulbert Caneus
Julbert Caneus
KAKaveena Autar
Kaveena Autar
NANesar Akanda
Nesar Akanda
MGMarcella Grillo
Marcella Grillo
CLChris Long
Chris Long
JHJames J. Hickman
James J. Hickman
Preclinical methods are needed for screening potential Alzheimer’s disease (AD) therapeutics that recapitulate phenotypes found in the Mild Cognitive Impairment (MCI) stage or even before this stage of the disease. This would require a phenotypic system that reproduces cognitive deficits without significant neuronal cell death to mimic the clinical manifestations of AD during these stages. A potential functional parameter to be monitored is long-term potentiation (LTP), which is a correlate of learning and memory, that would be one of the first functions effected by AD onset. Mature human iPSC-derived cortical neurons and primary astrocytes were co-cultured on microelectrode arrays (MEA) where surface chemistry was utilized to create circuit patterns connecting two adjacent electrodes to model LTP function. LTP maintenance was significantly reduced in the presence of Amyloid-Beta 42 (Aβ42) oligomers compared to the controls, however, co-treatment with AD therapeutics (Donepezil, Memantine, Rolipram and Saracatinib) corrected Aβ42 induced LTP impairment. The results presented here illustrate the significance of the system as a validated platform that can be utilized to model and study MCI AD pathology, and potentially for the pre-MCI phase before the occurrence of significant cell death. It also has the potential to become an ideal platform for high content therapeutic screening for other neurodegenerative diseases.